发明名称 |
TREATMENT METHOD USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATE |
摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide a treatment method of cancer in a mammal that is characterized by overexpression of an ErbB receptor, and does not respond or poorly responds to treatment using an anti-ErbB antibody. <P>SOLUTION: A therapeutically effective amount of a conjugate of an anti-ErbB receptor antibody and a maytansinoid is administered to the mammal. Further, a product suitable for using this method is provided. Concretely, the method is effective for cancer treatment targeting the ErbB receptor, using an anti-ErbB receptor antibody-maytansinoid conjugate. <P>COPYRIGHT: (C)2011,JPO&INPIT</p> |
申请公布号 |
JP2011105755(A) |
申请公布日期 |
2011.06.02 |
申请号 |
JP20110020019 |
申请日期 |
2011.02.01 |
申请人 |
GENENTECH INC;IMMUNOGEN INC |
发明人 |
ERICKSON SHARON;SCHWALL RALPH;SLIWKOWSKI MARK X;BLATTLER WALTER |
分类号 |
A61K39/395;A01K67/027;A61K31/537;A61K47/48;A61P1/00;A61P5/00;A61P11/00;A61P13/08;A61P13/10;A61P13/12;A61P15/00;A61P35/00;C07K16/28;C12N15/85 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|